These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6700460)
1. Cimetidine-theophylline interaction in patients with chronic obstructive airways disease. Roberts RK; Grice J; McGuffie C Med J Aust; 1984 Mar; 140(5):279-80. PubMed ID: 6700460 [TBL] [Abstract][Full Text] [Related]
2. Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids. Boehning W Eur J Clin Pharmacol; 1990; 38(1):43-5. PubMed ID: 2328746 [TBL] [Abstract][Full Text] [Related]
3. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration. Vestal RE; Thummel KE; Musser B; Mercer GD Br J Clin Pharmacol; 1983 Apr; 15(4):411-8. PubMed ID: 6849776 [TBL] [Abstract][Full Text] [Related]
4. The influence of orally administered cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction. Hsu K; Garton A; Sproule BJ; Tam YK; Legatt D; Herbert FA Am Rev Respir Dis; 1984 Nov; 130(5):740-3. PubMed ID: 6497156 [TBL] [Abstract][Full Text] [Related]
5. Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease. Dal Negro R; Pomari C; Turco P Clin Pharmacokinet; 1993 Mar; 24(3):255-8. PubMed ID: 8462230 [TBL] [Abstract][Full Text] [Related]
6. Cimetidine-theophylline interaction: report of four patients. Bauman JH; Kimelblatt BJ; Caraccio TR; Silverman HM; Simon GI; Beck GJ Ann Allergy; 1982 Feb; 48(2):100-2. PubMed ID: 6121526 [TBL] [Abstract][Full Text] [Related]
7. Comparative investigation of the influence of nizatidine, ranitidine, and cimetidine on the steady-state pharmacokinetics of theophylline in COPD patients. Bachmann K; Sullivan TJ; Mauro LS; Martin M; Jauregui L; Levine L J Clin Pharmacol; 1992 May; 32(5):476-82. PubMed ID: 1587967 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine. Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354 [TBL] [Abstract][Full Text] [Related]
9. Famotidine effects on theophylline pharmacokinetics in subjects affected by COPD. Comparison with cimetidine and placebo. Verdiani P; Di Carlo S; Baronti A Chest; 1988 Oct; 94(4):807-10. PubMed ID: 3168576 [TBL] [Abstract][Full Text] [Related]
10. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations]. Ranke C; Schmidt G; Oellerich M; Sybrecht GW Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564 [No Abstract] [Full Text] [Related]
11. Stable isotope methodology in a pharmacokinetic study of the interaction of theophylline and cimetidine. Vestal RE; Thummel KE; Musser B; Jue SG; Mercer GD; Howald WN Biomed Mass Spectrom; 1982 Aug; 9(8):340-6. PubMed ID: 7126765 [TBL] [Abstract][Full Text] [Related]
12. [Serum theophylline levels in chronic obstructive pulmonary disease patients receiving uniphyllin]. Chang SC; Perng RP Zhonghua Yi Xue Za Zhi (Taipei); 1988 Jan; 41(1):37-42. PubMed ID: 3167647 [No Abstract] [Full Text] [Related]
13. [Interaction between theophylline and cimetidine. Effect of cimetidine on the serum clearance of theophylline]. Sabaté Salvía I; Rodríguez Sanchón B; Barragán Rastrollo F; Frey González E; Escarrabill Sanglas J Med Clin (Barc); 1984 Sep; 83(7):286-8. PubMed ID: 6492917 [No Abstract] [Full Text] [Related]
14. The disposition of theophylline in blood in chronic obstructive lung disease. Ebden P; Banks J; Peel T; Buss DC; Routledge PA; Spragg BP Ther Drug Monit; 1986; 8(4):424-6. PubMed ID: 3824427 [TBL] [Abstract][Full Text] [Related]
15. Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease. Bachmann K; Sullivan TJ; Reese JH; Jauregui L; Miller K; Scott M; Yeh KC; Stepanavage M; King JD; Schwartz J J Clin Pharmacol; 1995 May; 35(5):529-35. PubMed ID: 7657856 [TBL] [Abstract][Full Text] [Related]
16. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease. Taylor DR; Duffin D; Kinney CD; McDevitt DG Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488 [TBL] [Abstract][Full Text] [Related]
17. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. McKay SE; Howie CA; Thomson AH; Whiting B; Addis GJ Thorax; 1993 Mar; 48(3):227-32. PubMed ID: 8497820 [TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of determining theophylline concentration in serum]. Bonelli J; Dellinger C; Kraus M; Waginger H; Zanic P Wien Med Wochenschr; 1986 Dec; 136(23-24):641-6. PubMed ID: 3564492 [No Abstract] [Full Text] [Related]
19. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation. Taylor DR; Kinney CD; McDevitt DG Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172 [No Abstract] [Full Text] [Related]